abstract |
The invention relates to medicine, namely to the pharmacotherapy of infectious diseases. The purpose of the invention is to increase specific antichlamydia activity. To do this, poly-2- -0,4-3-0-0-acetyl-D-glycopyranosyl 3-0-1-hydroxy-2- (salicylimino) ethyl-D-erythrofuranose is introduced into the organism infected with chlamydia as an antichlamydia drug. 3 tab, ё |